Resveratrol shows promise to protect hearing, cognition
Resveratrol, a substance found in red grapes and red wine, may have the potential to protect against hearing and cognitive decline, according to a published laboratory study from Henry Ford Hospital in Detroit.
Medical research
Feb 20, 2013 |
5 / 5 (1) |
0
|
Brain scientists present groundbreaking work at conference
(Medical Xpress)—Nearly 200 researchers recently met in Dallas to share important new findings and map strategies for identifying age-related dementias as early as possible.
Alzheimer's disease & dementia
Feb 18, 2013 |
not rated yet |
0
PSAs spotlight families dealing with Alzheimer's
Families who have lived with Alzheimer's disease share their personal stories and proclaim "Now Is the Moment" to end this life-shattering disease, in a moving set of public service announcements (PSAs).
Alzheimer's disease & dementia
Feb 14, 2013 |
1 / 5 (1) |
0
Gene is marker only for mild cognitive impairment
Defying the widely held belief that a specific gene is the biggest risk factor for Alzheimer's disease, two Cornell developmental psychologists and their colleagues report that people with that gene are more ...
Alzheimer's disease & dementia
Feb 12, 2013 |
5 / 5 (1) |
0
|
New hope for dementia sufferers
(Medical Xpress)—Research that aims to rid dementia sufferers' brains of toxins could lead to a new treatment that reverses the symptoms of Alzheimer's disease in the future.
Alzheimer's disease & dementia
Feb 08, 2013 |
not rated yet |
0
Cardiac disease linked to higher risk of mental impairment
Cardiac disease is associated with increased risk of mild cognitive impairment such as problems with language, thinking and judgment—particularly among women with heart disease, a Mayo Clinic study shows. Known as nonamnestic ...
Neuroscience
Jan 28, 2013 |
not rated yet |
0
|
First guidelines for brain amyloid imaging in Alzheimer's released
Only recently has it become possible to create high-quality images of the brain plaques characteristic of Alzheimer's disease in living people through positron emission tomography (PET). Even so, questions remain about what ...
Alzheimer's disease & dementia
Jan 28, 2013 |
not rated yet |
0
Right target, but missing the bulls-eye for Alzheimer's
(Medical Xpress)—Alzheimer's disease is the most common cause of late-life dementia. The disorder is thought to be caused by a protein known as amyloid-beta, or Abeta, which clumps together in the brain, forming plaques ...
Alzheimer's disease & dementia
Jan 24, 2013 |
5 / 5 (2) |
0
|
Tracing the impact of amyloid beta in mild cognitive impairment
The amount of amyloid β (Aβ) in the brains of people with mild cognitive impairment (MCI) is contributing to early memory loss, and increases with severity of symptoms, finds a study in BioMed Central's ...
Alzheimer's disease & dementia
Jan 15, 2013 |
not rated yet |
0
New test could help diagnose Alzheimer's disease in live patients
The patient turned 40 over the summer and was already having symptoms that made her neurologist wonder whether she had Alzheimer's disease, the deadly, mind-killing dementia that usually attacks far older people.
Alzheimer's disease & dementia
Dec 20, 2012 |
5 / 5 (2) |
0
Belgium looks at euthanasia for minors, Alzheimer's sufferers
Belgium is considering a significant change to its decade-old euthanasia law that would allow minors and Alzheimer's sufferers to seek permission to die.
Health
Dec 18, 2012 |
not rated yet |
0
Flaw in Alzheimer's drug trial test
New research led by Plymouth University Peninsula Schools of Medicine and Dentistry suggests that the cognitive test used in Alzheimer's drug trials is flawed.
Alzheimer's disease & dementia
Dec 16, 2012 |
5 / 5 (1) |
0
|
Lilly plans another study for Alzheimer's drug (Update)
Eli Lilly's experimental Alzheimer's drug has flashed potential to help with mild cases of the disease, but patients and doctors will have to wait a few more years to learn whether regulators will allow the drugmaker to sell ...
Alzheimer's disease & dementia
Dec 12, 2012 |
not rated yet |
0
Researchers make key discovery in fight against Alzheimer's disease
Medical researchers at the University of Alberta have discovered a drug intended for diabetes appears to restore memory in Alzheimer's brain cells.
Alzheimer's disease & dementia
Dec 11, 2012 |
4.8 / 5 (5) |
1
|
Study: 'ApoE is an ideal target for halting progression of Alzheimer's disease'
Despite researchers' best efforts, no drug exists that can slow, halt or reverse the onslaught of Alzheimer's disease. A progressive and fatal neurodegenerative disorder, Alzheimer's has stolen the memories and livelihoods ...
Alzheimer's disease & dementia
Dec 05, 2012 |
5 / 5 (1) |
0
|
